20.
Statutory Information The Company’s insurance subsidiaries prepare fi nancial statements on the basis of statutory accounting practices (“SAP”) prescribed or permitted by the insurance departments of their states of domicile.
Prescribed SAP includes the Accounting Practices and Procedures Manual of the National Association of Insurance Commissioners (“NAIC”) as well as state laws, regulations and administrative rules.
The principal differences between SAP and GAAP are: 1) policy acquisition costs are expensed as incurred under SAP, but are deferred and amortized under GAAP; 2) the value of business acquired is not capitalized under SAP but is under GAAP; 3) amounts collected from holders of universal lifetype and annuity products are recognized as premiums when collected under SAP, but are initially recorded as contract deposits under GAAP, with cost of insurance recognized as revenue when assessed and other contract charges recognized over the periods for which services are provided; 4) the classifi cation and carrying amounts of investments in certain securities are different under SAP than under GAAP; 5) the criteria for providing asset valuation allowances, and the methodologies used to determine the amounts thereof, are different under SAP than under GAAP; 6) the timing of establishing certain reserves, and the methodologies used to determine the amounts thereof, are different under SAP than under GAAP; 7) certain assets are not admitted for purposes of determining surplus under SAP; 8) methodologies used to determine the amounts of deferred taxes, intangible assets and goodwill are different under SAP than under GAAP; and 9) the criteria for obtaining reinsurance accounting treatment is different under SAP than under GAAP.
The combined statutory net income, excluding intercompany dividends and surplus note interest, and capital and surplus of the Company’s U. S.  domiciled statutory insurance subsidiaries follow:
## Table 0 ##
December 31,
## Table 1 ##
The Company also has non-insurance subsidiaries and foreign insurance subsidiaries that are not subject to SAP.
The statutory net income and statutory capital and surplus amounts presented above do not include foreign insurance subsidiaries in accordance with SAP.
Insurance enterprises are required by state insurance departments to adhere to minimum risk-based capital (“RBC”) requirements developed by the NAIC.
All of the Company’s insurance subsidiaries exceed minimum RBC requirements.
The payment of dividends to the Company by any of the Company’s regulated U.
S domiciled insurance subsidiaries in excess of a certain amount (i. e. , extraordinary dividends) must be approved by the subsidiary’s domiciliary state department of insurance.
Ordinary dividends, for which no regulatory approval is generally required, are limited to amounts determined by a formula, which varies by state.
The formula for the majority of the states in which the Company’s subsidiaries are domiciled is based on the prior year’s statutory net income or 10% of the statutory surplus as of the end of the prior year.
Some states limit ordinary dividends to the greater of these two amounts, others limit them to the lesser of these two amounts and some states exclude prior year realized capital gains from prior year net income in determining ordinary dividend capacity.
Some states have an additional stipulation that dividends may only be paid out of earned surplus.
If insurance regulators determine that payment of an ordinary dividend or any other payments by the Company’s insurance subsidiaries to the Company (such as payments under a tax sharing agreement or payments for employee or other services) would be adverse to policyholders or creditors, the regulators may block such payments that would otherwise be permitted without prior approval.
Based on the dividend restrictions under applicable laws and regulations, the maximum amount of dividends that the Company’s U.
S domiciled insurance subsidiaries could pay to the Company in 2015 without regulatory approval is approximately $476,000.
No assurance can be given that there will not be further regulatory actions restricting the ability of the Company’s insurance subsidiaries to pay dividends.
State regulators require insurance companies to meet minimum capitalization standards designed to ensure that they can fulfi ll obligations to policyholders.
Minimum capital requirements
HASBRO, INC.  AND SUBSIDIARIES Notes to Consolidated Financial Statements — (Continued) (Thousands of Dollars and Shares Except Per Share Data) The Tax Act contains a new law that requires a current inclusion in U. S.  federal taxable income of certain earnings of controlled foreign corporations, also known as the tax on global intangible low taxed income (GILTI), beginning in 2018.
The FASB has provided that companies subject to GILTI have the option to account for the GILTI tax as a period cost if and when incurred, or to recognize deferred taxes for temporary differences, including outside basis differences, expected to reverse as GILTI.
Due to the complexity of the new GILTI rules, we are continuing to evaluate this provision of the Tax Act.
We have not recorded any provisional amounts as of December 31, 2017 nor have we made an accounting policy choice of including taxable income related to GILTI as either a current period tax expense or factoring such amounts into our measurement of deferred taxes.
A reconciliation of unrecognized tax benefits, excluding potential interest and penalties, for the fiscal years ended December 31, 2017, December 25, 2016, and December 27, 2015 is as follows:
## Table 2 ##
Unrecognized tax benefits as of December 31, 2017, December 25, 2016 and December 27, 2015, were $84,244, $80,388, and $63,549, respectively.
If recognized, these tax benefits would have affected our income tax provision for fiscal years 2017, 2016, and 2015, by approximately $77,000, $70,000, and $59,000, respectively.
During 2017, 2016, and 2015 the Company recognized $2,431, $2,135, and $1,422, respectively, of potential interest and penalties, which are included as a component of income taxes in the accompanying consolidated statements of operations.
At December 31, 2017, December 25, 2016, and December 27, 2015, the Company had accrued potential interest and penalties of $5,157, $3,966, and $4,778, respectively.
The Company and its subsidiaries file income tax returns in the United States and various state and international jurisdictions.
In the normal course of business, the Company is regularly audited by U. S.  federal, state and local and international tax authorities in various tax jurisdictions.
The Company is no longer subject to U. S.  federal income tax examinations for years before 2013.
With few exceptions, the Company is no longer subject to U. S.  state or local and non-U.
S.  income tax examinations by tax authorities in its major jurisdictions for years before 2012.
The Company believes it is reasonably possible that a decrease of up to $2,800 in unrecognized tax benefits may be necessary within the coming year as a result of a lapse of statute of limitations.
(11) Capital Stock In February 2015, the Company’s Board of Directors authorized the repurchases of up to $500,000 in common stock.
Purchases of the Company’s common stock may be made from time to time, subject to market conditions, and may be made in the open market or through privately negotiated transactions.
The Company has no obligation to repurchase shares under the authorization and the time, actual number, and the value of the shares which are repurchased will depend on a number of factors, including the price of the Company’s common stock.
In 2017, the Company repurchased 1,584 shares at an average price of $94.74.
The total cost of these repurchases, including transaction costs, was $150,054.
At December 31, 2017, $177,966 remained under the current authorizations.
(12) Fair Value of Financial Instruments The Company measures certain assets at fair value in accordance with current accounting standards.
The fair value hierarchy consists of three levels: Level 1 fair values are valuations based on quoted market prices in active markets for identical assets or liabilities that the entity has the ability to access; Level 2 fair values are those valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the
real estate loans are individually reviewed by centralized loan review personnel each quarter to determine the appropriateness of the assigned loan grade, including whether the loan should be reported as accruing or nonaccruing.
Smaller balance criticized loans are analyzed by business line risk management areas to ensure proper loan grade classification.
Furthermore, criticized nonaccrual commercial loans and commercial real estate loans are considered impaired and, as a result, specific loss allowances on such loans are established within the allowance for credit losses to the extent appropriate in each individual instance.
The following table summarizes the loan grades applied to the various classes of the Company’s commercial loans and commercial real estate loans.
## Table 3 ##
In determining the allowance for credit losses, residential real estate loans and consumer loans are generally evaluated collectively after considering such factors as payment performance and recent loss experience and trends, which are mainly driven by current collateral values in the market place as well as the amount of loan defaults.
Loss rates on such loans are determined by reference to recent charge-off history and are evaluated (and adjusted if deemed appropriate) through consideration of other factors including near-term forecasted loss estimates developed by the Company’s Credit Department.
In arriving at such forecasts, the Company considers the current estimated fair value of its collateral based on geographical adjustments for home price depreciation/appreciation and overall borrower repayment performance.
With regard to collateral values, the realizability of such values by the Company contemplates repayment of any first lien position prior to recovering amounts on a second lien position.
However, residential real estate loans and outstanding balances of home equity loans and lines of credit that are more than 150 days past due are generally evaluated for collectibility on a loan-by-loan basis giving consideration to estimated collateral values.
The carrying value of residential real estate loans and home equity loans and lines of credit for which a partial charge-off has been recognized aggregated $63 million and $18 million, respectively, at December 31, 2014 and $58 million and $18 million, respectively, at December 31, 2013.
Residential real estate loans and home equity loans and lines of credit that were more than 150 days past due but did not require a partial charge-off because the net realizable value of the collateral exceeded the outstanding customer balance totaled $27 million and $28 million, respectively, at December 31, 2014 and $26 million and $21 million, respectively, at December 31, 2013.
The Company also measures additional losses for purchased impaired loans when it is probable that the Company will be unable to collect all cash flows expected at acquisition plus additional cash flows expected to be collected arising from changes in estimates after acquisition.
The determination of the allocated portion of the allowance for credit losses is very subjective.
Given that inherent subjectivity and potential imprecision involved in determining the allocated portion of the allowance for credit losses, the Company also provides an inherent unallocated portion of the allowance.
The unallocated portion of the allowance is intended to recognize probable losses that are not otherwise identifiable and includes management’s subjective determination of amounts necessary to provide for the possible use of imprecise estimates in determining the allocated portion of the allowance.
Therefore, the level of the unallocated portion of the allowance is primarily reflective of the inherent imprecision in the various calculations used
Item 6 — Selected Financial Data The following table presents NRG's historical selected financial data.
The data included in the following table has been recast to reflect the assets, liabilities and results of operations of certain projects that have met the criteria for treatment as discontinued operations in 2009.
This historical data should be read in conjunction with the Consolidated Financial Statements and the related notes thereto in Item 15 and Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations.
The Company has completed several acquisitions and dispositions, as described in Item 15 - Note 3, Business Acquisitions and Dispositions.
## Table 4 ##
(a) Liquidity position is determined as disclosed in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources, Liquidity Position.
It includes funds deposited by counterparties of $63 million, $271 million, and $258 million as of December 31, 2013, 2012, and 2011, respectively, which represents cash held as collateral from hedge counterparties in support of energy risk management activities.
It is the Company's intention to limit the use of these funds for repayment of the related current liability for collateral received in support of energy risk management activities.
(b) The Company recorded impairment losses in 2013 and 2011 as further described in Item 15 - Note 10, Asset Impairments.

<table><tr><td></td><td colspan="3"> Years Ended December 31,</td></tr><tr><td></td><td> 2014</td><td> 2013</td><td> 2012</td></tr><tr><td>Statutory net income</td><td></td><td></td><td></td></tr><tr><td>P&C companies</td><td>$440,930</td><td>$457,068</td><td>$371,520</td></tr><tr><td>Life and Health companies</td><td>67,270</td><td>148,851</td><td>223,519</td></tr><tr><td>Total statutory net income</td><td>$508,200</td><td>$605,919</td><td>$595,039</td></tr></table>
<table><tr><td></td><td colspan="2"> December 31,</td></tr><tr><td></td><td> 2014</td><td> 2013</td></tr><tr><td>Statutory capital and surplus</td><td></td><td></td></tr><tr><td>P&C companies</td><td>$1,396,305</td><td>$1,440,394</td></tr><tr><td>Life and Health companies</td><td>1,064,174</td><td>923,660</td></tr><tr><td>Total statutory capital and surplus</td><td>$2,460,479</td><td>$2,364,054</td></tr></table>
<table><tr><td></td><td>2017</td><td>2016</td><td>2015</td></tr><tr><td>Balance at beginning of year</td><td>$80,388</td><td>63,549</td><td>35,416</td></tr><tr><td>Gross increases in prior period tax positions</td><td>2,518</td><td>2,727</td><td>491</td></tr><tr><td>Gross decreases in prior period tax positions</td><td>-28,653</td><td>-3,103</td><td>-1,773</td></tr><tr><td>Gross increases in current period tax positions</td><td>34,056</td><td>34,155</td><td>32,547</td></tr><tr><td>Decreases related to settlements with tax authorities</td><td>-1,375</td><td>-11,662</td><td>-355</td></tr><tr><td>Decreases from the expiration of statute of limitations</td><td>-2,690</td><td>-5,278</td><td>-2,777</td></tr><tr><td>Balance at end of year</td><td>$84,244</td><td>80,388</td><td>63,549</td></tr></table>
<table><tr><td></td><td></td><td colspan="3"> Real Estate</td></tr><tr><td></td><td> Commercial, Financial, Leasing, etc</td><td> Commercial</td><td> Residential Builder and Developer</td><td> Other Commercial Construction</td></tr><tr><td></td><td colspan="4"> (In thousands)</td></tr><tr><td>December 31, 2014</td><td></td><td></td><td></td><td></td></tr><tr><td>Pass</td><td>$18,695,440</td><td>$21,837,022</td><td>$1,347,778</td><td>$3,347,522</td></tr><tr><td>Criticized accrual</td><td>588,407</td><td>578,317</td><td>45,845</td><td>172,269</td></tr><tr><td>Criticized nonaccrual</td><td>177,445</td><td>141,600</td><td>71,517</td><td>25,699</td></tr><tr><td>Total</td><td>$19,461,292</td><td>$22,556,939</td><td>$1,465,140</td><td>$3,545,490</td></tr><tr><td>December 31, 2013</td><td></td><td></td><td></td><td></td></tr><tr><td>Pass</td><td>$17,894,592</td><td>$20,972,257</td><td>$1,107,144</td><td>$3,040,106</td></tr><tr><td>Criticized accrual</td><td>699,885</td><td>596,553</td><td>72,941</td><td>54,464</td></tr><tr><td>Criticized nonaccrual</td><td>110,739</td><td>173,048</td><td>96,427</td><td>35,268</td></tr><tr><td>Total</td><td>$18,705,216</td><td>$21,741,858</td><td>$1,276,512</td><td>$3,129,838</td></tr></table>
<table><tr><td></td><td colspan="5">Year Ended December 31,</td></tr><tr><td></td><td>2013</td><td>2012</td><td>2011</td><td>2010</td><td>2009</td></tr><tr><td></td><td colspan="5">(In millions except ratios and per share data)</td></tr><tr><td>Statement of income data:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total operating revenues</td><td>$11,295</td><td>$8,422</td><td>$9,079</td><td>$8,849</td><td>$8,952</td></tr><tr><td>Total operating costs and expenses, and other expenses<sup>(b)</sup></td><td>11,929</td><td>8,434</td><td>9,725</td><td>8,119</td><td>7,283</td></tr><tr><td>(Loss)/Income from continuing operations, net</td><td>-352</td><td>315</td><td>197</td><td>476</td><td>941</td></tr><tr><td>Net (loss)/income attributable to NRG Energy, Inc.</td><td>$-386</td><td>$295</td><td>$197</td><td>$477</td><td>$942</td></tr><tr><td>Common share data:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Basic shares outstanding — average</td><td>323</td><td>232</td><td>240</td><td>252</td><td>246</td></tr><tr><td>Diluted shares outstanding — average</td><td>323</td><td>234</td><td>241</td><td>254</td><td>271</td></tr><tr><td>Shares outstanding — end of year</td><td>324</td><td>323</td><td>228</td><td>247</td><td>254</td></tr><tr><td>Per share data:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Net (loss)/income attributable to NRG — basic</td><td>-1.22</td><td>1.23</td><td>0.78</td><td>1.86</td><td>3.70</td></tr><tr><td>Net (loss)/income attributable to NRG — diluted</td><td>-1.22</td><td>1.22</td><td>0.78</td><td>1.84</td><td>3.44</td></tr><tr><td>Dividends declared per common share</td><td>$0.45</td><td>$0.18</td><td>$—</td><td>$—</td><td>$—</td></tr><tr><td>Book value</td><td>$32.33</td><td>$31.83</td><td>$33.71</td><td>$32.65</td><td>$29.72</td></tr><tr><td>Business metrics:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cash flow from operations</td><td>$1,270</td><td>$1,149</td><td>$1,166</td><td>$1,623</td><td>$2,106</td></tr><tr><td>Liquidity position<sup>(a)</sup></td><td>$3,695</td><td>$3,362</td><td>$2,328</td><td>$4,660</td><td>$3,971</td></tr><tr><td>Ratio of earnings to fixed charges</td><td>0.30</td><td>0.86</td><td>0.77</td><td>2.03</td><td>3.27</td></tr><tr><td>Ratio of earnings to fixed charges and preferred dividends</td><td>0.29</td><td>0.85</td><td>0.76</td><td>1.99</td><td>3.04</td></tr><tr><td>Return on equity</td><td>-3.69%</td><td>2.87%</td><td>2.57%</td><td>5.91%</td><td>12.24%</td></tr><tr><td>Ratio of debt to total capitalization</td><td>57.60%</td><td>56.74%</td><td>52.43%</td><td>42.94%</td><td>43.49%</td></tr><tr><td>Balance sheet data:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Current assets</td><td>$7,596</td><td>$7,972</td><td>$7,749</td><td>$7,137</td><td>$6,208</td></tr><tr><td>Current liabilities</td><td>4,204</td><td>4,670</td><td>5,861</td><td>4,220</td><td>3,762</td></tr><tr><td>Property, plant and equipment, net</td><td>19,851</td><td>20,153</td><td>13,621</td><td>12,517</td><td>11,564</td></tr><tr><td>Total assets</td><td>33,902</td><td>34,983</td><td>26,900</td><td>26,896</td><td>23,378</td></tr><tr><td>Long-term debt, including current maturities, capital leases, and funded letter of credit</td><td>16,817</td><td>15,883</td><td>9,832</td><td>10,511</td><td>8,418</td></tr><tr><td>Total stockholders' equity</td><td>$10,469</td><td>$10,269</td><td>$7,669</td><td>$8,072</td><td>$7,697</td></tr></table>

Question: What is the total amount of Life and Health companies of Years Ended December 31, 2012, and Balance at end of year of 2015 ?
Answer: 287068